FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911772511> ?p ?o ?g. }

• W2911772511 endingPage "1620" @default.
• W2911772511 startingPage "1615" @default.
• W2911772511 abstract "Ixazomib-Revlimid-Dexamethasone is an all-oral treatment protocol for multiple myeloma with a manageable tolerability profile which was available through a named patient program for Hungarian patients from December 2015 to April 2017. We analyzed the clinical characteristics and survival of 77 patients treated at 7 centers within this program. The majority of patients responded, we found complete response in 9, very good partial response in 8, partial response in 32, minor response or stable disease in 13 and progressive disease in 11 patients. Progression free survival was 11.4 months. There was a trend of longer progression free survival in those with 1 vs. >1 prior treatment, with equally good effectivity in standard risk and high risk cytogenetic groups. The adverse events were usually mild, none leading to permanent drug interruptions. There were 5 fatalities: 3 infections and 2 pulmonary embolisms. Our real word data support the use of Ixazomib-Revlimid-Dexamethasone as a highly effective and well tolerated oral treatment protocol for relapsed myeloma." @default.
• W2911772511 created "2019-02-21" @default.
• W2911772511 creator A5000633148 @default.
• W2911772511 creator A5001705439 @default.
• W2911772511 creator A5006303201 @default.
• W2911772511 creator A5007822782 @default.
• W2911772511 creator A5009065083 @default.
• W2911772511 creator A5010760298 @default.
• W2911772511 creator A5012342629 @default.
• W2911772511 creator A5023879246 @default.
• W2911772511 creator A5037693976 @default.
• W2911772511 creator A5049774064 @default.
• W2911772511 creator A5058002325 @default.
• W2911772511 creator A5063244357 @default.
• W2911772511 creator A5066803583 @default.
• W2911772511 creator A5068281424 @default.
• W2911772511 creator A5074843807 @default.
• W2911772511 date "2019-02-02" @default.
• W2911772511 modified "2023-10-18" @default.
• W2911772511 title "Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program" @default.
• W2911772511 cites W2014737912 @default.
• W2911772511 cites W2044436186 @default.
• W2911772511 cites W2343386476 @default.
• W2911772511 cites W2728870144 @default.
• W2911772511 cites W2740395975 @default.
• W2911772511 cites W2766948867 @default.
• W2911772511 cites W2781661609 @default.
• W2911772511 cites W2791800253 @default.
• W2911772511 cites W2799641062 @default.
• W2911772511 cites W2800852870 @default.
• W2911772511 doi "https://doi.org/10.1007/s12253-019-00607-2" @default.
• W2911772511 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6815275" @default.
• W2911772511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30712192" @default.
• W2911772511 hasPublicationYear "2019" @default.
• W2911772511 type Work @default.
• W2911772511 sameAs 2911772511 @default.
• W2911772511 citedByCount "23" @default.
• W2911772511 countsByYear W29117725112019 @default.
• W2911772511 countsByYear W29117725112020 @default.
• W2911772511 countsByYear W29117725112021 @default.
• W2911772511 countsByYear W29117725112022 @default.
• W2911772511 countsByYear W29117725112023 @default.
• W2911772511 crossrefType "journal-article" @default.
• W2911772511 hasAuthorship W2911772511A5000633148 @default.
• W2911772511 hasAuthorship W2911772511A5001705439 @default.
• W2911772511 hasAuthorship W2911772511A5006303201 @default.
• W2911772511 hasAuthorship W2911772511A5007822782 @default.
• W2911772511 hasAuthorship W2911772511A5009065083 @default.
• W2911772511 hasAuthorship W2911772511A5010760298 @default.
• W2911772511 hasAuthorship W2911772511A5012342629 @default.
• W2911772511 hasAuthorship W2911772511A5023879246 @default.
• W2911772511 hasAuthorship W2911772511A5037693976 @default.
• W2911772511 hasAuthorship W2911772511A5049774064 @default.
• W2911772511 hasAuthorship W2911772511A5058002325 @default.
• W2911772511 hasAuthorship W2911772511A5063244357 @default.
• W2911772511 hasAuthorship W2911772511A5066803583 @default.
• W2911772511 hasAuthorship W2911772511A5068281424 @default.
• W2911772511 hasAuthorship W2911772511A5074843807 @default.
• W2911772511 hasBestOaLocation W29117725111 @default.
• W2911772511 hasConcept C126322002 @default.
• W2911772511 hasConcept C141071460 @default.
• W2911772511 hasConcept C143998085 @default.
• W2911772511 hasConcept C197934379 @default.
• W2911772511 hasConcept C2776063141 @default.
• W2911772511 hasConcept C2776364478 @default.
• W2911772511 hasConcept C2778375690 @default.
• W2911772511 hasConcept C2780108899 @default.
• W2911772511 hasConcept C2780401358 @default.
• W2911772511 hasConcept C2781098529 @default.
• W2911772511 hasConcept C71924100 @default.
• W2911772511 hasConceptScore W2911772511C126322002 @default.
• W2911772511 hasConceptScore W2911772511C141071460 @default.
• W2911772511 hasConceptScore W2911772511C143998085 @default.
• W2911772511 hasConceptScore W2911772511C197934379 @default.
• W2911772511 hasConceptScore W2911772511C2776063141 @default.
• W2911772511 hasConceptScore W2911772511C2776364478 @default.
• W2911772511 hasConceptScore W2911772511C2778375690 @default.
• W2911772511 hasConceptScore W2911772511C2780108899 @default.
• W2911772511 hasConceptScore W2911772511C2780401358 @default.
• W2911772511 hasConceptScore W2911772511C2781098529 @default.
• W2911772511 hasConceptScore W2911772511C71924100 @default.
• W2911772511 hasFunder F4320321102 @default.
• W2911772511 hasIssue "4" @default.
• W2911772511 hasLocation W29117725111 @default.
• W2911772511 hasLocation W29117725112 @default.
• W2911772511 hasLocation W29117725113 @default.
• W2911772511 hasLocation W29117725114 @default.
• W2911772511 hasLocation W29117725115 @default.
• W2911772511 hasOpenAccess W2911772511 @default.
• W2911772511 hasPrimaryLocation W29117725111 @default.
• W2911772511 hasRelatedWork W2200095709 @default.
• W2911772511 hasRelatedWork W2345487218 @default.
• W2911772511 hasRelatedWork W2389385859 @default.
• W2911772511 hasRelatedWork W2618355916 @default.
• W2911772511 hasRelatedWork W2803498787 @default.
• W2911772511 hasRelatedWork W3027894540 @default.
• W2911772511 hasRelatedWork W3163088375 @default.
• W2911772511 hasRelatedWork W3213371026 @default.

• next